955406-28-7

Basic information

• Product Name: (3R,5S)-5-[3-(2,6-dichloro-4-hydroxy-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester
• Synonyms: (3R,5S)-5-[3-(2,6-dichloro-4-hydroxy-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester
• CAS NO: 955406-28-7
• Molecular Weight: 480.391
• Mol File: 955406-28-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3R,5S)-5-[3-(2,6-dichloro-4-hydroxy-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,5S)-5-[3-(2,6-dichloro-4-hydroxy-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester(955406-28-7)
• EPA Substance Registry System: (3R,5S)-5-[3-(2,6-dichloro-4-hydroxy-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester(955406-28-7)

Safety Data

• Hazardous Substances Data: 955406-28-7(Hazardous Substances Data)

Upstream product

• 179321-49-4 N-(tert-butoxycarbonyl)-4-aminocyclohexanone 
• 955406-16-3 (3R,5S)-3-(4-benzyloxy-2,6-dichloro-benzyl)-1-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-pyrrolidin-2-one 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1158767-01-1 (+/-)-(4,5,6,7-Tetrahydro-2H-indazol-5-yl)-carbamic acid tert-butyl ester 
• 955373-72-5 (R)-4-benzyl-3-[(S)-2-(4-benzyloxy-2,6-dichloro-benzyl)-pent-4-enoyl]-oxazolidin-2-onecf 
• 955373-73-6 (R)-4-((R)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-(4-benzyloxy-2,6-dichloro-benzyl)-4-oxo-butyraldehyde 
• 1171130-67-8 (3-dimethylaminomethylene-4-oxo-cyclohexyl)-carbamic acid tert-butyl ester 
• 955406-26-5 (3R,5S)-5-[3-(4-benzyloxy-2,6-dichloro-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester 
• 955406-25-4 (3R,5S)-5-[3-(4-benzyloxy-2,6-dichloro-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-2-carboxylic acid tert-butyl ester 

Relevant articles and documents

CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1

The present invention discloses novel compounds of Formula (I): having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compound